OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Deciphering mechanisms affecting cefepime-taniborbactam in vitro activity in carbapenemase-producing Enterobacterales and carbapenem-resistant Pseudomonas spp. isolates recovered during a surveillance study in Spain
Marta Hernández-García, María García-Castillo, Marta Nieto-Torres, et al.
European Journal of Clinical Microbiology & Infectious Diseases (2023) Vol. 43, Iss. 2, pp. 279-296
Closed Access | Times Cited: 10
Marta Hernández-García, María García-Castillo, Marta Nieto-Torres, et al.
European Journal of Clinical Microbiology & Infectious Diseases (2023) Vol. 43, Iss. 2, pp. 279-296
Closed Access | Times Cited: 10
Showing 10 citing articles:
Carbapenem-Resistant Enterobacteriaceae in Urinary Tract Infections: From Biological Insights to Emerging Therapeutic Alternatives
Eugenio Bologna, Leslie Claire Licari, Celeste Manfredi, et al.
Medicina (2024) Vol. 60, Iss. 2, pp. 214-214
Open Access | Times Cited: 8
Eugenio Bologna, Leslie Claire Licari, Celeste Manfredi, et al.
Medicina (2024) Vol. 60, Iss. 2, pp. 214-214
Open Access | Times Cited: 8
Cefepime–Taniborbactam: A Novel Cephalosporin/β-Lactamase Inhibitor Combination
George G. Zhanel, Celine Mansour, Stacey Mikolayanko, et al.
Drugs (2024) Vol. 84, Iss. 10, pp. 1219-1250
Closed Access | Times Cited: 5
George G. Zhanel, Celine Mansour, Stacey Mikolayanko, et al.
Drugs (2024) Vol. 84, Iss. 10, pp. 1219-1250
Closed Access | Times Cited: 5
Cefepime–taniborbactam activity against antimicrobial-resistant clinical isolates of Enterobacterales and Pseudomonas aeruginosa: GEARS global surveillance programme 2018–22
James A. Karlowsky, Mark G. Wise, Meredith Hackel, et al.
Journal of Antimicrobial Chemotherapy (2024)
Open Access | Times Cited: 5
James A. Karlowsky, Mark G. Wise, Meredith Hackel, et al.
Journal of Antimicrobial Chemotherapy (2024)
Open Access | Times Cited: 5
Difficult-to-Treat Pseudomonas aeruginosa Infections in Critically Ill Patients: A Comprehensive Review and Treatment Proposal
Pablo Vidal, Sandra Campos-Fernández, Elena Cuenca-Fito, et al.
Antibiotics (2025) Vol. 14, Iss. 2, pp. 178-178
Open Access
Pablo Vidal, Sandra Campos-Fernández, Elena Cuenca-Fito, et al.
Antibiotics (2025) Vol. 14, Iss. 2, pp. 178-178
Open Access
Emerging resistance mechanisms to newer β-lactams in Pseudomonas aeruginosa
Antonio Oliver, Jorge Arca-Suárez, María A. Gomis-Font, et al.
Clinical Microbiology and Infection (2025)
Closed Access
Antonio Oliver, Jorge Arca-Suárez, María A. Gomis-Font, et al.
Clinical Microbiology and Infection (2025)
Closed Access
Impact of porin deletions on cefepime-taniborbactam activity against Klebsiella pneumoniae
Tsuyoshi Uehara, Cassandra L. Chatwin, Brittany Miller, et al.
Antimicrobial Agents and Chemotherapy (2025)
Open Access
Tsuyoshi Uehara, Cassandra L. Chatwin, Brittany Miller, et al.
Antimicrobial Agents and Chemotherapy (2025)
Open Access
A Review of In Silico and In Vitro Approaches in the Fight Against Carbapenem‐Resistant Enterobacterales
Muhammad Absar, Abdul Rahman Zaidah, Amer Mahmood, et al.
Journal of Clinical Laboratory Analysis (2025)
Open Access
Muhammad Absar, Abdul Rahman Zaidah, Amer Mahmood, et al.
Journal of Clinical Laboratory Analysis (2025)
Open Access
ARGONAUT-III and -V: susceptibility of carbapenem-resistant Klebsiella pneumoniae and multidrug-resistant Pseudomonas aeruginosa to the bicyclic boronate β-lactamase inhibitor taniborbactam combined with cefepime
Michael R. Jacobs, Ayman M. Abdelhamed, Caryn E. Good, et al.
Antimicrobial Agents and Chemotherapy (2024) Vol. 68, Iss. 9
Open Access | Times Cited: 3
Michael R. Jacobs, Ayman M. Abdelhamed, Caryn E. Good, et al.
Antimicrobial Agents and Chemotherapy (2024) Vol. 68, Iss. 9
Open Access | Times Cited: 3
Therapies in preclinical and in early clinical development for the treatment of urinary tract infections: from pathogens to therapies
Virginia Fuochi, Salvatore Furnari, Laura Trovato, et al.
Expert Opinion on Investigational Drugs (2024) Vol. 33, Iss. 7, pp. 677-698
Closed Access | Times Cited: 2
Virginia Fuochi, Salvatore Furnari, Laura Trovato, et al.
Expert Opinion on Investigational Drugs (2024) Vol. 33, Iss. 7, pp. 677-698
Closed Access | Times Cited: 2
Survival of infection with TEM β-lactamase-producing Escherichia coli with Pan-β-lactam resistance
Ángel Rodríguez-Villodres, José Manuel Ortiz de la Rosa, Lydia Gálvez-Benítez, et al.
Journal of Infection (2024), pp. 106268-106268
Open Access | Times Cited: 1
Ángel Rodríguez-Villodres, José Manuel Ortiz de la Rosa, Lydia Gálvez-Benítez, et al.
Journal of Infection (2024), pp. 106268-106268
Open Access | Times Cited: 1
Not all carbapenem-resistant Pseudomonas aeruginosa strains are alike: tailoring antibiotic therapy based on resistance mechanisms
Marco Falcone, Valentina Galfo, Giusy Tiseo
Current Opinion in Infectious Diseases (2024) Vol. 37, Iss. 6, pp. 594-601
Open Access
Marco Falcone, Valentina Galfo, Giusy Tiseo
Current Opinion in Infectious Diseases (2024) Vol. 37, Iss. 6, pp. 594-601
Open Access
